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Background:
Video assisted thoracoscopic surgery (VATS) has become the recommended approach for treatment of resectable lung cancer. However, no large randomized clinical trial has been conducted formally comparing surgical resections completed by VATS to those done by open thoracotomy (OT) in low volume centers. The current study sought to assess differences in recurrence-free survival (RFS), overall survival (OS), positive margins and postoperative length of stay (LOS) between VATS and OT lobectomies in our center.
Method:
A single institution retrospective chart review from May 2005 through May 2015 was conducted. All patients diagnosed with stage I through III lung cancer who underwent surgical resection were selected.
Patient and tumor characteristics recorded included age at diagnosis, sex, tobacco use, tumor location (side and lobe), stage, size and receipt of chemotherapy or radiotherapy. Chis-square and WilcoxonMann-Whitney tests were used to compare demographics, tumor characteristics and LOS. Multiple logistic and Cox regression analyses were used to compute relative risk (RR) for positive margins and mortality hazard ratios along with 95 percent confidence intervals (95%CI), respectively.
Results:
Of the 235 patients, 101 subjects had VATS while OT was performed in 134 patients. Age at diagnosis, sex, tobacco use, tumor location, and size were comparable for VATS and OT. No significant difference was observed in the relative risk of positive margins for VATS versus OT, RR = 0.56 (95%CI = 0.26, 1.05). However, VATS had shorter median LOS compared to OT (4 vs. 6 days, respectively), p = 0.002.
A comparison of VATS versus OT showed no significant difference in the risk of recurrence, HR = 1.21 (95%CI = 0.74, 2.00), or death, HR = 1.34 (95%CI = 0.88, 2.06), in the intent-to-treat population.
Similarly, no significant differences in recurrence or mortality risk were observed between VATS versus OT for analyses conducted separately for each cancer stage group or those limited to patients with negative margins.
INTRODUCTION:
Surgical resection remains the mainstay of treatment in resectable lung cancers. The introduction of video assisted thoracoscopic surgery (VATS) in 1994 [1] sparked interest in minimally invasive tumor resection. VATS has also been shown to have fewer postoperative complications [2] and has been associated with decreased postoperative pain and increased quality of life compared to OT [3] . Several studies have compared these two approaches indirectly, but no randomized controlled trial has investigated the long-term effect on outcomes. We sought to investigate the long-term disease-free survival and overall survival of patients with lung cancer undergoing lung resection by OT or VATS for resectable stage lung cancer.
PATIENTS AND METHODS:
Surgical Methods:
VATS lung resections were performed via a three-port incision technique including a 4-centimeter anterior axillary working port. The specimens were removed via the working port. Rib spreading was not required. A hilar dissection proceeding from anterior to posterior was performed for lobectomies. For OT resections, a standard posterolateral thoracotomy was used. Generally, bulky tumors, inability to tolerate one lung ventilation, dense adhesions, en bloc chest wall resections, sleeve resections, neoadjuvant radiation therapy, or intraoperative complications were reasons for selecting an OT approach or for requiring a conversion from VATS to OT.
Study population:
Records for patients diagnosed with stage I through III resectable lung cancer treated at Loma Linda 
Study outcomes:
Recurrence-free survival was the primary outcome and overall survival was the secondary outcome.
Survival was calculated from the date of surgery to the date of recurrence diagnosis/death or end of study follow-up (May 2016).
Study covariates:
Patient and tumor characteristics included age at diagnosis, sex, tobacco use, tumor location (side and lobe), stage, size and type of the treatments including chemotherapy or radiotherapy.
Statistical analyses:
Tumor and demographic characteristics were compared using Chis-square and Wilcoxon-Mann-Whitney tests. Purposeful variable selection approach was used to identify covariates that were included in the final models. A covariate-adjusted Cox proportional hazards model was used to compare recurrence-free and overall survival between patients treated with VATS and those treated with OT. Profile likelihood was used to estimate 95 percent confidence intervals. Proportionality was assessed using Shoenfeld residuals correlations and log-log survival plots. All tests were conducted using R software. R Core Team (Table 2 and Table 3 (Table 4) , which have compared VATS to OT. As noted in the table, these studies consistently showed decreased length of stay and no difference in three to five-year disease free or overall survival. Our data is consistent with other data sets retrospectively comparing VATS and OT for resection of resectable non-small cell lung cancer [8, 26] .
VATS lobectomy seems to have similar oncological outcomes as OT lobectomy. In VATS lobectomy the incisions are smaller and rib spreading is not performed. These patients are likely to have an overall faster recovery and may tolerate adjuvant chemotherapy better. They are also likely to have less post-operative complications and hence more likely to start and complete adjuvant chemotherapy in a timely fashion possibly leading to improved long-term outcome [15, 27] .
Our study has several limitations. First and most importantly, our study is a single institution retrospective study. Specific information on patient selection criteria as well as differences in surgeons' experience is lacking and may have led to selection bias. VATS, like all newly developed minimally invasive surgical techniques, requires skills and experience in which not all surgeons have been trained.
